ARWR · US market
Arrowhead Pharmaceuticals Inc
Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.
Market cap US$9.15bnFinancials dated 30 June 2026Price dated 1 October 2026
Core valuation
Calculation inputs
- Trailing earnings
- -US$319.95m
- Latest-quarter run-rate earnings
- -US$777.12m
- Latest fiscal-year earnings
- -US$1.63m
- Trailing revenue
- US$669.50m
- Latest-quarter run-rate revenue
- US$301.01m
- Latest fiscal-year revenue
- US$829.45m
Featured ETF and mutual-fund exposure
These public funds report this company in their latest disclosed holdings.
- IBRN · iShares Neuroscience and Healthcare ETF4.42% weight · Holdings dated 21 August 2026
- GNOM · Global X Genomics & Biotechnology ETF3.95% weight · Holdings dated 31 May 2026
- FBT · First Trust NYSE Arca Biotechnology Index Fund3.38% weight · Holdings dated 30 June 2026
- IBBQ · Invesco Nasdaq Biotechnology ETF3.28% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- PBE · Invesco Biotechnology & Genome ETF3.28% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- RFG · Invesco S&P MidCap 400 Pure Growth ETF2.32% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- PTH · Invesco Dorsey Wright Healthcare Momentum ETF1.93% weight · Holdings dated 19 August 2026
- XMMO · Invesco S&P MidCap Momentum ETF1.64% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- OMFS · Invesco Russell 2000 Dynamic Multifactor ETF1.41% weight · Holdings dated 31 May 2026
- XBI · State Street SPDR S&P Biotech ETF1.11% weight · Holdings dated 21 August 2026
Sources and limitations
Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.
Open financial sourceFinancials as of 30 June 2026. Informational research, not investment advice.